Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Pozzilli

Showing results (141-150 of 247) with videos related to

Pageof 25
Sort By:
Multiple Sclerosis and Related Disorders|November 6, 2024
Improvement of fatigue, depression, and processing speed two weeks post Natalizumab infusion in Multiple Sclerosis: No difference between standard and extended interval dosing schedulesGiorgio Leodori, Marco Mancuso, Davide Maccarrone, et al.
Scientific Reports|July 31, 2024
Insight into motor fatigue mechanisms in natalizumab treated multiple sclerosis patients with wearing offGiorgio Leodori, Marco Mancuso, Davide Maccarrone, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 25, 2014
Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trialTomas Olsson, Aaron Boster, Óscar Fernández, et al.
Journal of Neurology|May 10, 2021
Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosisSilvia Tommasin, Sirio Cocozza, Alessandro Taloni, et al.
Medicina (Kaunas, Lithuania)|March 29, 2023
Potential Protective Role of Pregnancy and Breastfeeding in Delaying Onset Symptoms Related to Multiple SclerosisAlessandra Logoteta, Maria Grazia Piccioni, Riccardo Nistri, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 29, 2025
Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched studyElena Barbuti, Alessia Castiello, Valeria Pozzilli, et al.
Journal of the Neurological Sciences|March 4, 2026
Predictors of short-term, relapse-independent progression in multiple sclerosis: A machine learning approach based on clinical data and conventional MRI-derived featuresAntonio Ianniello, Elena Barbuti, Maria Francesca Capobianco, et al.
European Journal of Neurology|March 31, 2021
Scoring the 10-year risk of ambulatory disability in multiple sclerosis: the RoAD scoreClaudio Gasperini, Luca Prosperini, Àlex Rovira, et al.
Neurobiology of Disease|March 11, 2023
Neural bases of motor fatigue in multiple sclerosis: A multimodal approach using neuromuscular assessment and TMS-EEGGiorgio Leodori, Marco Mancuso, Davide Maccarrone, et al.
Pharmacological Research|October 18, 2012
Fingolimod protects cultured cortical neurons against excitotoxic deathLuisa Di Menna, Gemma Molinaro, Luigi Di Nuzzo, et al.
Pageof 25

Showing results (141-150 of 247) with videos related to

Sort By:
Pageof 25
Multiple Sclerosis and Related Disorders|November 6, 2024
Improvement of fatigue, depression, and processing speed two weeks post Natalizumab infusion in Multiple Sclerosis: No difference between standard and extended interval dosing schedulesGiorgio Leodori, Marco Mancuso, Davide Maccarrone, et al.
Scientific Reports|July 31, 2024
Insight into motor fatigue mechanisms in natalizumab treated multiple sclerosis patients with wearing offGiorgio Leodori, Marco Mancuso, Davide Maccarrone, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 25, 2014
Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trialTomas Olsson, Aaron Boster, Óscar Fernández, et al.
Journal of Neurology|May 10, 2021
Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosisSilvia Tommasin, Sirio Cocozza, Alessandro Taloni, et al.
Medicina (Kaunas, Lithuania)|March 29, 2023
Potential Protective Role of Pregnancy and Breastfeeding in Delaying Onset Symptoms Related to Multiple SclerosisAlessandra Logoteta, Maria Grazia Piccioni, Riccardo Nistri, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 29, 2025
Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched studyElena Barbuti, Alessia Castiello, Valeria Pozzilli, et al.
Journal of the Neurological Sciences|March 4, 2026
Predictors of short-term, relapse-independent progression in multiple sclerosis: A machine learning approach based on clinical data and conventional MRI-derived featuresAntonio Ianniello, Elena Barbuti, Maria Francesca Capobianco, et al.
European Journal of Neurology|March 31, 2021
Scoring the 10-year risk of ambulatory disability in multiple sclerosis: the RoAD scoreClaudio Gasperini, Luca Prosperini, Àlex Rovira, et al.
Neurobiology of Disease|March 11, 2023
Neural bases of motor fatigue in multiple sclerosis: A multimodal approach using neuromuscular assessment and TMS-EEGGiorgio Leodori, Marco Mancuso, Davide Maccarrone, et al.
Pharmacological Research|October 18, 2012
Fingolimod protects cultured cortical neurons against excitotoxic deathLuisa Di Menna, Gemma Molinaro, Luigi Di Nuzzo, et al.
Pageof 25